High-purity oritavancin and method for producing the same

摘要

High purity oritavancin drug substance preparations are disclosed along with pharmaceutical compositions comprising such oritavancin drug substance formulations and pharmaceuticals or dosage forms comprising such pharmaceutical compositions. [Selection] Figure 1